Web Stats Provided By Google Analytics

Thursday, July 11, 2013

Biodel Inc. Announces Completion of Dosing in Phase 2 Clinical Trial...

... With Type 1 Diabetes Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! DANBURY, Conn., July 11, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced that all scheduled follow-up visits have been ...



via Danbury Newswire http://www.biospace.com/news_story.aspx?StoryID=302445&full=1

No comments:

Post a Comment

The Raw Danbury Blog And RSS Feed

Popular Posts Danbury Roundup Posts